Abstract
Mutations in the UMOD gene encoding uromodulin (Tamm-Horsfall glycoprotein) result in the autosomal dominant transmission of progressive renal insufficiency and hypo-uricosuric hyperuricemia leading to gout at an early age. The clinical appearance is characterized by renal insufficiency and gout occurring in the late teenage years, with end-stage kidney disease characteristically developing between 40 and 70 years of age. This report provides a long-term characterization of renal functional decline in three children from one family with a novel UMOD mutation (c.891T>G, p.C297W) who received allopurinol and a low protein diet. While renal functional decline is slow in individuals with UMOD mutations, it may appear early in life and be associated with marked hyperuricemia. Anemia was also noted in this family.
Similar content being viewed by others
References
Hart TC, Gorry MC, Hart PS, Woodard AS, Shihabi Z, Sandhu J, Shirts B, Xu L, Zhu H, Barmada MM, Bleyer AJ (2002) Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 39:882–892
Gusmano R, Caridi G, Marini M, Perfumo F, Ghiggeri G, Piaggio G, Ceccherini I, Seri M (2002) Glomerulocystic kidney disease in a family. Nephrol Dial Transplant 17:813–818
Lens XM, Banet JF, Outeda P, Barrio-Lucia V (2005) A novel pattern of mutation in uromodulin disorders: Autosomal dominant medullary cystic kidney disease type 2, familial juvenile hyperuricemic nephropathy, and autosomal dominant glomerulocystic kidney disease. Am J Kidney Dis 46:52–57
Turner J, Stacey J, Harding B, Kotanko K, Lhotta J, Puig J, Roberts I, Torres R, Thakker R (2003) Uromodulin mutations cause familial juvenile hyperuricemic nephropathy. J Clin Endocrinol Metab 88:1398–1401
Dahan K, Devuyst O, Smaers M, Vertommen D, Loute G, Poux J-M, Viron B, Jacquot C, Gagnadoux M-F, Chauveau D, Buchler M, Cochat P, Cosyns J-P, Mougenot B, Rider MH, Antignac C, Verellen-Dumoulin C, Pirson Y (2003) A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol 14:2883–2893
Serafini-Cessi F, Malagolini N, Cavallone D (2003) Tamm-Horsfall glycoprotein biology and clinical relevance. Am J Kidney Dis 42:658–676
Malagolini N, Cavallone D, Serafini-Cessi F (1997) Intracellular transport, cell-surface exposure and release of recombinant Tamm-Horsfall glycoprotein. Kidney Int 52:1340–1350
Scolari F, Caridi G, Rampoldi L, Tardanico R, Izzi C, Pirulli D, Amoroso A, Casari G, Ghiggeri GM (2004) Uromodulin storage diseases: clinical aspects and mechanisms. Am J Kidney Dis 44:987–999
Hoyer JR, Sisson SP, Vernier RL (1979) Tamm-Horsfall glycoprotein ultrastructural immunoperoxidase localization in rat kidney. Lab Invest 41:168–173
Raffi HS, Bates JM, Laszik Z, Kumar S (2009) Tamm-Horsfall protein protects against urinary tract infection by proteus mirabilis. J Vasc Surg 181:2332–2338
Hess B (2004) Tamm-Horsfall glycoprotein and calcium nephrolithiasis. Miner Electrolyte Metab 20:393–398
Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M, Yang Q, Gudnason V, Launer LJ, Harris TB, Smith AV, Arking DE, Astor BC, Boerwinkle E, Ehret GB, Ruczinski I, Scharpf RB, Chen I, deBoer IH, Haritunians T, Lumley T (2009) Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41:712–717
Hildebrandt F, Omram H (2001) New insights: nephronophthisis-medullary cystic kidney disease. Pediatr Nephrol 16:168–176
Wolf MTF, Karle SM, Schwarz S, Anlauf M, Anlauf M, Glaeser L, Kroiss S, Burton C, Feest T, Otto E, Fuchshuber A, Hilderbrant F (2003) Refinement of the critical region for MCKD1 by detection of transcontinental haplotype sharing. Kidney Int 64:788–792
Giselson N, Heinegard N, Holmberg C-G, Lindberg L-G, Lindstedt E, Lindstedt G, Schersten B (1970) Renal medullary cystic disease or familial juvenile nephronophthisis: a renal tubular disease. Am J Med 48:174–184
Hildebrandt F, Otto E (2006) Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease? Nat Rev Genet 6:928–940
Wolf MTF, Mucha BE, Attanasio M, Zalewski I, Karle SM, Neumann HPH, Rahman N, Bader B, Baldamus CA, Otto E, Witzgall R, Fuchshuber A, Hildebrandt F (2003) Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains. Kidney Int 64:1580–1587
Bleyer AJ, Woodard AS, Shihabi Z, Sandhu J, Zhu H, Satko SG, Weller N, Deterding E, McBride D, Gorry MC, Xu L, Ganier D, Hart TC (2003) Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. Kidney Int 64:36–42
Choi SW, Ryu OH, Choi SJ, Song IS, Bleyer AJ, Hart TC (2005) Mutant Tamm-Horsfall glycoprotein accumulation in the endoplasmic reticulum induces apoptosis that is reversed by colchicine and sodium 4-phenylbutyrate. J Am Soc Nephrol 16:3006–3014
Wolf MTE, Beck BB, Zaucke F, Kunze A, Misselwitz J, Ruley J, Ronda T, Fischer A, Eifinger F, Licht C, Otto E, Hoppe B, Hildebrandt F (2007) The uromodulin C744G mutation causes MCKD2 and FJHN in children and adults and may be due to a possible founder effect. Kidney Int 71:574–581
Yu KH, See LC, Huang YC, Yang CH, Sun JH (2007) Dietary factors associated with hyperuricemia in adults. Semin Arthritis Rheum 37:243–250
Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877–884
Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G (2008) Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. Clin J Am Soc Nephrol 3:1511–1525
Bleyer AJ, Trachtman H, Sandhu J, Gorry MC, Hart TC (2003) Renal manifestations of a mutation in the uromodulin (Tamm-Horsfall protein) gene. Am J Kidney Dis 42:1–7
Fairbanks L, Cameron J, Venkata-Raman G, Rigden S, Rees L, van’t Hoff W, Mansell M, Pattison J, Goldsmith D, Simmonds H (2002) Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. Q J Med 95:597–607
Moro F, Simmonds HA, Cameron JS, Ogg CS, Williams GD, McBride MB, Davis PM (1991) Does allopurinol affect the progression of familial juvenile gouty nephropathy? Adv Exp Med Biol 309A:199–202
Bleyer AJ, Hart TC (2003) Familial juvenile hyperuricaemic nephropathy. Q J Med 96:867–868
Parra E, Gota R, Gamen A, Moros M, Azuara M (1995) Granulomatous interstitial nephritis secondary to allopurinol treatment. Clin Nephrol 43:350
Acknowledgments
The authors thank Victoria Robins, R.N. for her valuable help.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schäffer, P., Gombos, É., Meichelbeck, K. et al. Childhood course of renal insufficiency in a family with a uromodulin gene mutation. Pediatr Nephrol 25, 1355–1360 (2010). https://doi.org/10.1007/s00467-009-1436-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-009-1436-y